Social Determinants Study for Prostate Cancer

Age: 18+

Sex: Male

Trial Phase: Academic

Sponsor: M.D. Anderson Cancer Center

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how migration history affects the quality of life for Black immigrant prostate cancer (CaP) survivors. Researchers aim to understand the various social and environmental factors impacting these individuals' experiences in the U.S. Participants will engage in interviews to share their stories and insights. Men who identify as Black or African American, have been diagnosed with prostate cancer in the last 10 years, and have a U.S. address are suitable for this study. As an unphased trial, this study provides a unique opportunity to contribute personal experiences to enhance understanding and support for Black immigrant prostate cancer survivors.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to explore the social determinants of health (SDOH) model to understand prostate cancer among Black immigrants. Unlike traditional treatments that focus primarily on medical interventions, this approach involves interviews to gather insights into how social factors like environment, economic status, and community impact prostate cancer outcomes. By using this novel method, the trial seeks to uncover potentially overlooked influences on health that could lead to more personalized and effective strategies for prevention and treatment in this specific population.

Who Is on the Research Team?

Lorna McNeill, MPH,PHD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

This study is for Black immigrant men who have been diagnosed with prostate cancer and are from Sub-Saharan Africa or the Caribbean. It focuses on understanding how their migration history affects their life after cancer treatment.

Inclusion Criteria

I am a man aged 18 or older.

Self-identify as CI and SSAI

Self-identify as Black or African American

Exclusion Criteria

Not applicable.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Theory Study

Participants are recruited and studied using the SDOH model to understand the impact of migration history on prostate cancer care and survivorship

12 months

Follow-up

Participants are monitored for safety and effectiveness after the study

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Interviews

Trial Overview The trial involves conducting interviews to explore a range of factors such as race, social environment, behavior, and structural influences that affect the health outcomes of these men in the context of U.S. society.

How Is the Trial Designed?

Group I: Theory Study of the Black Immigrant using a SDOH Model Experimental Treatment 1 Intervention

Participants will be recruited by utilizing the MD Anderson Cancer Registry

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials

3,107

Recruited

1,813,000+